We have previously evaluated the mRNA levels of FL BARD1 in high-risk neuroblastomas compared with low and intermediate risk neuroblastomas and in patients with favorable neuroblastomas (Stage 4s) compared to metastatic neuroblastomas (Stage 4) 36. Here, BARD1 is linked to neuroblastoma.